AIBT on OTC
AIBOTICS, INC.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with Cannaisseur Group Inc., NEUTRA CORP. or NUTRA PHARMA CORP, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Interest100¢$226.9K
Out of $2.2K in revenue.3 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | $2.2K | $0 |
| GROSS PROFIT | $2.2K | $0 |
| General and administrative | $1.8M | $1.6M |
| TOTAL OPERATING EXPENSES | $1.8M | $1.6M |
| NET LOSS FROM OPERATIONS | -$1.8M | -$1.6M |
| Interest expense | -$226.9K | -$213.5K |
| Loss on extinguishment of liabilities | -$144.2K | $0 |
| TOTAL OTHER EXPENSE | -$371.1K | -$213.5K |
| NET LOSS BEFORE PROVISION FOR INCOME TAXES | -$2.2M | -$1.8M |
| Provision for income taxes | $0 | $0 |
| NET LOSS | -$2.2M | -$1.8M |
| AVERAGE NUMBER OF COMMON SHARE OUTSTANDING - BASIC | -$0 | -$0 |
| AVERAGE NUMBER OF COMMON SHARE OUTSTANDING - DILUTED | -$0 | -$0 |
| AVERAGE NUMBER OF COMMON SHARE OUTSTANDING - BASIC AND DILUTED | 186.3M shares | 13.4M shares |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2024-06-30 |
|---|---|---|---|
| Cash | $255.9K | $185.1K | |
| Prepaid expenses | $14.2K | $0 | |
| TOTAL CURRENT ASSETS | $270.1K | $185.1K | |
| Intangible assets, net | $604.6K | $1.3M | |
| TOTAL ASSETS | $874.7K | $1.5M | |
| Accounts payable and accrued expenses | $532.3K | $283.3K | |
| Accrued expenses - related party | $807.0K | $864.0K | |
| Accrued interest | $216.7K | $399.8K | |
| Convertible note payable, net of debt discount | $1.1M | $1.1M | |
| Note payable - related party | $165.0K | $165.0K | |
| Shares to be issued | $2.0M | $2.0M | |
| TOTAL LIABILITIES | $4.8M | $4.9M | |
| TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT | $874.7K | $1.5M | |
| Common stock, $0.001 par value, 7,500,000,000 467,000,000,shares authorized; 486,895,359 and 39,990,903, shares issued and outstanding, at December 31, 2025 and December 31, 2024, respectively | $486.9K | $40.0K | |
| Additional paid-in capital | $8.6M | $7.4M | |
| Accumulated deficit | -$13.0M | -$10.8M | |
| TOTAL STOCKHOLDERS' DEFICIT | -$4.0M | -$3.4M | |
| Preferred Stock, Shares Authorized | 5.0M shares | 5.0M shares | |
| Common Stock, Par or Stated Value Per Share | $0.00 | $0.00 | |
| Common Stock, Shares Authorized | 7.5B shares | 467.0M shares | 467.0M shares |
| Common Stock, Shares, Issued | 486.9M shares | 40.0M shares | |
| Common Stock, Shares, Outstanding | 486.9M shares | 40.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$2.2M | -$1.8M |
| Depreciation expense | $0 | $498 |
| Amortization expense | $667.3K | $667.9K |
| Loss recognized on common stock issued to settle liability | $144.2K | $79.6K |
| Amortization of debt discount | $17.0K | $9.3K |
| Decrease in prepaid expense | $35.8K | $0 |
| Accounts payable and accrued expenses | $732.6K | $339.8K |
| Accrued interest | -$7.4K | $204.1K |
| Accrued expenses - related party | $168.0K | $288.0K |
| NET CASH USED IN OPERATING ACTIVITES | -$458.2K | -$259.0K |
| Proceeds from convertible note payable | $300.0K | $0 |
| Proceeds from the issuance of common stock | $279.1K | $0 |
| Proceeds from related party note payable | $0 | $165.0K |
| Repayments of convertible note payable | -$50.0K | $0 |
| NET CASH PROVIDED BY FINANCING ACTIVITES | $529.1K | $165.0K |
| NET CHANGE IN CASH | $70.8K | -$94.0K |
| Cash paid for interest | $0 | $0 |
| Cash paid for income taxes | $0 | $0 |
| Common stock issued to settle accounts payable and accrued expenses | $363.2K | $477.4K |
| Common stock issued to settle accrued expenses - related party | $225.0K | $0 |
| Common stock issued for cash and settlement of accrued interest, net of issuance costs | $876.9K | $0 |
| Issuance of common stock in exchange for consulting services | $50.0K | $0 |
| Shares to be issued | $44.0K | $44.0K |
| Exchange of common stock for Series A Preferred Stock | $0 | $9.8K |
| Issuance of Preferred Series B | $0 | $4.4K |
Former names
Recent filings
- Oct 5, 20268-K AIBOTICS, INC. - FORM 8-K SEC FILING
- Aug 19, 202610-Q AIBOTICS, INC. - FORM 10-Q SEC FILING
- Aug 14, 2026NT 10-Q FORM NT 10-Q FILING
- Jun 9, 202610-Q AIBOTICS, INC. - FORM 10-Q SEC FILING
- May 15, 2026NT 10-Q FORM NT 10-Q FILING
- Apr 15, 202610-K AIBOTICS, INC. - FORM 10-K SEC FILING
- Mar 31, 2026NT 10-K AIBOTICS, INC.- NT10K
- Jan 28, 2026S-8 AIBOTICS INC. - FORM S-8 FILING
- Nov 19, 202510-Q AIBOTICS, INC. - FORM 10-Q SEC FILING
- Nov 14, 2025NT 10-Q FORM NT 10-Q FILING
- Aug 19, 202510-Q AIBOTICS, INC. - FORM 10-Q SEC FILING
- Aug 14, 2025NT 10-Q FORM NT 10-Q FILING
- Jul 28, 20254 PRIMARY DOCUMENT
- Jul 3, 2025253G2 AIBOTICS FORM 253(G)(2)
- Jul 1, 2025QUALIF
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAIBOTICS, INC. filings on SEC EDGAR
- 2SEC EDGARAIBOTICS, INC. filings on SEC EDGAR
- 3SEC EDGARAIBOTICS, INC. 10-K for fiscal 2025
- 4SEC EDGARAIBOTICS, INC. 10-K for fiscal 2019
- 5SEC EDGARAIBOTICS, INC. 10-K for fiscal 2020
- 6SEC EDGARAIBOTICS, INC. 10-K for fiscal 2021
- 7SEC EDGARAIBOTICS, INC. 10-K for fiscal 2022
- 8SEC EDGARAIBOTICS, INC. 10-K for fiscal 2023
- 9SEC EDGARAIBOTICS, INC. 10-K for fiscal 2019
- 10SEC EDGARAIBOTICS, INC. 10-Q for fiscal 2026
- 11SEC EDGARAIBOTICS, INC. 10-Q for fiscal 2026
- 12SEC EDGARAIBOTICS, INC. 10-K for fiscal 2019